{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:45:12Z","timestamp":1773233112858,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003648","name":"National Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpddr.2025.100621","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:59:14Z","timestamp":1760072354000},"page":"100621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a clinical risk scoring system for artesunate treatment failure prediction in malaria patients"],"prefix":"10.1016","volume":"29","author":[{"given":"Dasom","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-2563","authenticated-orcid":false,"given":"Hye Sun","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijpddr.2025.100621_bib1","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/cid\/ciab570","article-title":"Safety and effectiveness of intravenous artesunate for treatment of severe malaria in the United States\u2014April 2019 through December 2020","volume":"73","author":"Abanyie","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100621_bib2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1186\/s12879-021-06961-4","article-title":"Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005\u20132018","volume":"21","author":"Abuaku","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100621_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12936-017-1796-x","article-title":"Patterns of inflammatory responses and parasite tolerance vary with malaria transmission intensity","volume":"16","author":"Ademolue","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100621_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100087","article-title":"Possible mechanisms of the hypoglycaemic effect of artesunate: gender implication","volume":"10","author":"Alagbonsi","year":"2021","journal-title":"Metab open"},{"key":"10.1016\/j.ijpddr.2025.100621_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s40264-018-0667-x","article-title":"Safety experience during real-world use of injectable artesunate in public health facilities in Ghana and Uganda: outcomes of a modified cohort event monitoring study (CEMISA)","volume":"41","author":"Ampadu","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.ijpddr.2025.100621_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpddr.2020.11.006","article-title":"Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: a systematic review of clinical studies from two malaria endemic regions\u2013India and Sub-Saharan Africa","volume":"15","author":"Arya","year":"2021","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"4","key":"10.1016\/j.ijpddr.2025.100621_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s15010-022-01771-5","article-title":"Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study","volume":"50","author":"Botta","year":"2022","journal-title":"Infection"},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100621_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e2552eb7-a70c-46f5-aca6-7526c56fb151","article-title":"Severe imported falciparum malaria: a cohort study in 400 critically ill adults","volume":"5","author":"Bruneel","year":"2010","journal-title":"PLoS One"},{"issue":"9753","key":"10.1016\/j.ijpddr.2025.100621_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","article-title":"Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial","volume":"376","author":"Dondorp","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100621_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12936-021-03720-3","article-title":"Predictors of treatment failures of Plasmodium falciparum malaria in Vietnam: a 4-year single-centre retrospective study","volume":"20","author":"Duong","year":"2021","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100621_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1179\/2047773212Y.0000000032","article-title":"Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre","volume":"106","author":"Eder","year":"2012","journal-title":"Pathog. Glob. Health"},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100621_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/QCO.0000000000000199","article-title":"Understanding artemisinin-resistant malaria: what a difference a year makes","volume":"28","author":"Fairhurst","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100621_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-339","article-title":"Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator","volume":"10","author":"Flegg","year":"2011","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100621_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4269\/ajtmh.17-0101","article-title":"Malaria-related hospitalizations in the United States, 2000\u20132014","volume":"97","author":"Khuu","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2025.100621_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-11-102","article-title":"Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium","volume":"11","author":"Kreeftmeijer-Vegter","year":"2012","journal-title":"Malar. J."},{"issue":"9","key":"10.1016\/j.ijpddr.2025.100621_bib17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/cid\/civ575","article-title":"Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: the TropNet severe malaria study","volume":"61","author":"Kurth","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100621_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijid.2021.02.080","article-title":"Recrudescence of a high parasitaemia, severe Plasmodium falciparum malaria episode, treated by artesunate monotherapy","volume":"105","author":"Landre","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100621_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3346\/jkms.2018.33.e121","article-title":"Treatment outcomes of imported Plasmodium falciparum malaria with intravenous artesunate","volume":"33","author":"Lee","year":"2022","journal-title":"J Korean Soc Emerg Med"},{"key":"10.1016\/j.ijpddr.2025.100621_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0638-y","article-title":"Severe malaria in Canada, 2001\u20132013","volume":"14","author":"McCarthy","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100621_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2471\/BLT.12.109124","article-title":"Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009\u20132010","volume":"90","author":"Mishra","year":"2012","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijpddr.2025.100621_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-284","article-title":"Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India","volume":"13","author":"Mishra","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2025.100621_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03520-1","article-title":"Asymptomatic recrudescence after artemether\u2013lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis","volume":"19","author":"Mumtaz","year":"2020","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.ijpddr.2025.100621_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw093","article-title":"Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications","volume":"24","author":"Roussel","year":"2017","journal-title":"J. Trav. Med."},{"issue":"10","key":"10.1016\/j.ijpddr.2025.100621_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/cid\/ciab133","article-title":"Intravenous artesunate for the treatment of severe imported malaria: implementation, efficacy, and safety in 1391 patients","volume":"73","author":"Roussel","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2025.100621_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2019.101505","article-title":"Imported malaria and artemisinin-based combination therapy failure in travellers returning to Belgium: a retrospective study","volume":"32","author":"Rovira-Vallbona","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"issue":"9487","key":"10.1016\/j.ijpddr.2025.100621_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","article-title":"Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijpddr.2025.100621_bib28","first-page":"CD007483","article-title":"Artemisinin\u2010based combination therapy for treating uncomplicated malaria","author":"Sinclair","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpddr.2025.100621_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11910-022-01214-6","article-title":"Neurological complications of malaria","volume":"22","author":"Trivedi","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.ijpddr.2025.100621_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00016-8","article-title":"The 2023 WHO World malaria report","volume":"5","author":"Venkatesan","year":"2024","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.ijpddr.2025.100621_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"Woodrow","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2025.100621_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70148","article-title":"The immunomodulatory role of estrogen in malaria: a review of sex differences and therapeutic implications","volume":"13","author":"Wu","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"issue":"5","key":"10.1016\/j.ijpddr.2025.100621_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3201\/eid1705.101229","article-title":"Intravenous artesunate for severe malaria in travelers, Europe","volume":"17","author":"Zoller","year":"2011","journal-title":"Emerg. Infect. Dis."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320725000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:21:16Z","timestamp":1773159676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320725000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S2211320725000442"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100621","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a clinical risk scoring system for artesunate treatment failure prediction in malaria patients","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2025.100621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}],"article-number":"100621"}}